UNSPSC 51361705: Butoctamide semisuccinate

This classification denotes a sedative and hypnotic with the molecular formula C16H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F58251NT6M, chemically known as butanedioic acid, 1-(3-((2-ethylhexyl)amino)-1-methyl-3-oxopropyl) ester, but more generally known as butoctamide semisuccinate, which bears US NIH Compound Identifier 2486. European Medicines Agency schedules butoctamide semisuccinate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06028MIG.

Most nations, for tariff purposes, schedule butoctamide semisuccinate under HS 29241900. SMILES: CCCCC(CC)CNC(=O)CC(C)OC(=O)CCC(=O)O.

UNSPSC 51361705 Butoctamide semisuccinate is a Commodity code that nominally covers a specific pharmaceutical compound, but recent state and local solicitation activity shows no procurement directly aligned with this narrow chemical specification. The three most recent opportunities tagged under this code pursue naloxone and drug deactivation systems, therapeutic pharmacy initiative direct-to-manufacturer prescriptions, and generic multi-source pharmaceuticals and over-the-counter products—none of which center on butoctamide semisuccinate or reference it in their scope. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), indicating activity across county, state, and cooperative procurement channels. The mismatch between the code's chemical focus and the actual work being bought suggests either a tagging error in the source data or that butoctamide semisuccinate is infrequently procured as a standalone line item under state and local contracts.

Geographic activity centers in Florida, Texas, and Minnesota based on the three most recent opportunities. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with bids due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, gathering vendor capabilities for direct-to-manufacturer prescription fulfillment without pharmacy benefit managers or wholesalers. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative, released an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. Given the absence of butoctamide-specific procurement in these solicitations, the code shows little relevant recent activity for firms targeting pharmaceutical commodity sales at the state and local level.